India continues to lead the world in terms of average daily cases detected. As of April 15, India recorded 1,75,910 daily cases on an average. With 70,483 average daily cases, the U.S. was a distant second followed by Brazil with 66,689 average new cases. However, in terms of average daily deaths, India (952) was second to Brazil (2917).
Here are the latest updates:
Bharat Biotech to make 6 crore Covaxin doses by July
The production of indigenously developed Covaxin vaccine will be doubled by May-June and then increased nearly 6-7 fold by July-August 2021. Bharat Biotech makes 1 crore doses a month now. Production may reach nearly 10 crore doses a month by September, the Department of Biotechnology said on Friday.
The DBT has funded three state-run facilities — the Haffkine Biopharmaceutical Corporation Ltd, Mumbai; Indian Immunologicals Limited, Hyderabad and Biologicals Limited, Bulandsh-ahr — to make vaccines. Haffkine has been given ₹65 crore but it will take anywhere between 6-12 months to be able to produce the vaccine; the other two facilities are expected to begin producing 10-15 million doses a month by August
Researchers propose method to treat rare blood clotting reaction to vaccine
The U.S. on April 13 paused the use of Johnson and Johnson’s vaccine following adverse reactions in a few vaccinated persons while investigations are on to understand the mechanism of the rare reaction better. This followed the fact that six people in about 7 million vaccinated with J&J’s vaccine developed blood clots in the days following vaccination.
A similar adverse reaction to AstraZeneca’s vaccine has been observed in rare cases. In this situation, a German and Austrian group, led by Andreas Greinacher of University Medicine Greifswald, in Germany, has announced a partial understanding of this mechanism and a possible method of treatment.
Several districts face vaccine shortage in Tamil Nadu
A shortage of COVID-19 vaccines was reported from a number of districts across Tamil Nadu. While a few districts have already run out of Covaxin, the available stocks of Covishield will last only a few days in a number of districts.
Many districts were looking for fresh supplies to continue vaccination. The surge in cases has led to an increase in demand for the vaccines, resulting in quick depletion of the stocks, a section of health officials
Migrants leaving city in hordes, but not due to lockdown fears
Despite the Delhi government announcing weekend lockdown, migrant workers in the Capital appear not to be leaving the city yet, though they’re gathering at transport hubs in hordes. Most migrant workers The Hindu spoke to at Anand Vihar ISBT said they are going home for reasons other than lockdown fear and plan to return.
Some, however, were scared that the weekend lockdown might extend. Vir Singh (33) from Uttar Pradesh’s Badaun, sat with his wife, children and other family members with eight pieces of luggage and said he was scared if the lockdown will extend. However, they will come back if the lockdown is not announced, he said.
Yediyurappa met hundreds of people since April 14
The news of Chief Minister B.S. Yediyurappa testing positive for COVID-19 again has created a scare among the political and bureaucratic circles as he had attended an official meeting on Friday and a slew of political rallies in bypoll-bound Belagavi on Wednesday and Thursday.
On Friday morning, just before he was confimed COVID-19 positive, he had chaired a meeting on COVID-19 with senior officers and Health and Family Welfare and Medical Education Minister K. Sudhakar.
‘Adolescent girls face more pressure during pandemic’
Twenty five girls from seven cities set out to interview their peers to record the impact of COVID-19 on their lives and found that adolescent girls were grappling with an increased pressure to get married, spent longer hours on household chores, lacked tools to continue school education online, and reported an increase in gender-based violence.
(With inputs from our Correspondents and agencies)